AXT, Inc.
NASDAQ:AXTISemiconductors
-$2.72 today
- Market cap
- $2.39B
- Beta
- 1.81
- P/E (TTM)
- -338.5
- EPS (TTM)
- -$0.26
Volume 12.93M
Average 11.66M
AXTI Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
AXT, Inc.NASDAQ: AXTI
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development growth accelerates
Q3 FY2026 research & development of $3.94M rose 289.3% year over year, ahead of the +20.5% change in trailing-twelve-month research & development. Sequentially, it rose 8.0% from the prior quarter. Over 3 fiscal years it compounded at -13.4% a year.
Context
- Research & development amounted to 10.2% of revenue in FY2025, down 4.4 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +289.3% holds above the trailing-twelve-month pace of +20.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 9.05M USD
- Year-over-year change
- -37.8%
- 4-year CAGR
- -3.3%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 9.05M | -37.8% |
| FY2024 | 2024-12-31 | 14.54M | +20.4% |
| FY2023 | 2023-12-31 | 12.08M | -13.2% |
| FY2022 | 2022-12-31 | 13.91M | +34.7% |
| FY2021 | 2021-12-31 | 10.33M | — |
Research & Development vs competitors
How AXTI compares with its peers on the latest reported figures
- AXTI's LTM Sep 2026 research & development of $13M is the 4th highest of the 5 companies compared; the peer median is $198.54M.
- Its year-over-year change of +20.5% is the 4th highest of 5, against a peer median of +42.1%.
- Research & development amounts to 7.6% of revenue for AXTI, versus a peer median of 20.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $356.5M | +17.3% | +5.0% | 11.8% | |
| LTM Jul 2026 | $272.63M | +21.4% | +18.1% | 23.4% | |
| LTM Sep 2026 | $124.46M | +62.8% | +33.1% | 16.7% | |
| LTM Sep 2026 | $13M | +20.5% | -13.4% | 7.6% | |
| LTM Mar 2026 | $2.55M | +65.5% | +6.8% | 49.1% | |
| Peer median (excluding AXTI) | $198.54M | +42.1% | +12.5% | 20.0% | |
Competitors are the stored peer set for AXTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 137.39M | 141.12M | 75.8M | 99.36M | 88.33M |
| Cost of Revenue | 89.98M | 89M | 62.48M | 75.53M | 77.08M |
| Gross Profit | 47.41M | 52.12M | 13.32M | 23.84M | 11.24M |
| Gross Margin | 34.5% | 36.9% | 17.6% | 24.0% | 12.7% |
| Research & Development | 10.33M | 13.91M | 12.08M | 14.54M | 9.05M |
| Selling, General & Admin | 24.19M | 25.65M | 22.81M | 24.1M | 24.17M |
| Operating Expenses | 34.52M | 39.57M | 34.89M | 38.64M | 33.22M |
| Depreciation & Amortization | 7.08M | 8.12M | 8.72M | 8.98M | 9.11M |
| EBITDA | 25.1M | 30.12M | (8.78M) | (338K) | (11.18M) |
| EBITDA Margin | 18.3% | 21.3% | -11.6% | -0.3% | -12.7% |
| Operating Income | 12.9M | 12.55M | (21.57M) | (14.8M) | (21.98M) |
| Operating Margin | 9.4% | 8.9% | -28.5% | -14.9% | -24.9% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 213K | 1.07M | 1.53M | 1.34M | 1.26M |
| Other Income / Expenses | 4.71M | 8.37M | 2.54M | 4.15M | 432K |
| Income Before Tax | 17.6M | 20.93M | (19.03M) | (10.66M) | (21.54M) |
| Pre-Tax Margin | 12.8% | 14.8% | -25.1% | -10.7% | -24.4% |
| Income Tax Expense | 1.09M | 2.19M | 160K | 1.13M | 1.66M |
| Net Income | 14.58M | 15.81M | (17.88M) | (11.62M) | (21.26M) |
| Net Margin | 10.6% | 11.2% | -23.6% | -11.7% | -24.1% |
| EPS (Basic) | 0.35 | 0.37 | (0.42) | (0.27) | (0.49) |
| EPS (Diluted) | 0.34 | 0.37 | (0.42) | (0.27) | (0.49) |
| Weighted Avg Shares | 41.37M | 42.1M | 42.64M | 43.15M | 43.93M |
| Weighted Avg Shares (Diluted) | 42.72M | 42.72M | 42.64M | 43.15M | 43.93M |
AXT, Inc.
NASDAQ:AXTI
Intrinsic Alpha fair value
Locked
Current Price
$36.42
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.